| Hailey Marn Roberts, MD | |
|
3213 Stein Blvd, Eau Claire, WI 54701-6946 | |
| (715) 836-9242 | |
| Not Available |
| Full Name | Hailey Marn Roberts |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 3213 Stein Blvd, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497252589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 81035 (Wisconsin) | Primary |
| Entity Name | Oakleaf Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679870315 PECOS PAC ID: 4486831328 Enrollment ID: O20110602000195 |
News Archive
Females find same-sex social interactions to be more rewarding than males, and females are more sensitive to the rewarding actions of oxytocin (OT) than males, according to a research study led by Georgia State University on the brain mechanisms that determine the rewarding properties of social interactions.
In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.
Quidel Corporation (NASDAQ: QDEL), a global leader in point-of-care (POC) rapid diagnostic tests, received Special 510(k) clearance for an update to the Company's QuickVue® Influenza A+B test package insert to include reactivity with culture isolates of the 2009 H1N1 Influenza A virus.
MicroVAX, LLC, a biotech company located in Manassas, Virginia announced today the commencement of a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the, breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy.
Neuroptis, a company specialized in the development of drugs to treat eye disorders, today announces positive results from a second animal trial of its preservative-free ML7 eye drops. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye syndrome.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hailey Marn Roberts, MD 719 W Hamilton Ave Ste B, Eau Claire, WI 54701-6970 Ph: (715) 552-9784 | Hailey Marn Roberts, MD 3213 Stein Blvd, Eau Claire, WI 54701-6946 Ph: (715) 836-9242 |
News Archive
Females find same-sex social interactions to be more rewarding than males, and females are more sensitive to the rewarding actions of oxytocin (OT) than males, according to a research study led by Georgia State University on the brain mechanisms that determine the rewarding properties of social interactions.
In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.
Quidel Corporation (NASDAQ: QDEL), a global leader in point-of-care (POC) rapid diagnostic tests, received Special 510(k) clearance for an update to the Company's QuickVue® Influenza A+B test package insert to include reactivity with culture isolates of the 2009 H1N1 Influenza A virus.
MicroVAX, LLC, a biotech company located in Manassas, Virginia announced today the commencement of a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the, breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy.
Neuroptis, a company specialized in the development of drugs to treat eye disorders, today announces positive results from a second animal trial of its preservative-free ML7 eye drops. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye syndrome.
› Verified 9 days ago
Dr. Steven D Stenzel, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1030 Oak Ridge Dr, Eau Claire, WI 54701 Phone: 715-861-6100 Fax: 715-831-8250 | |
Dr. Laura Leigh Ambler, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Melissa L Emmerich, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2116 Craig Road, Eau Claire, WI 54701 Phone: 715-858-4630 | |
Dr. Gabriela Palecek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Jordan Crow, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3213 Stein Blvd, Eau Claire, WI 54701 Phone: 715-836-9242 Fax: 715-836-7847 | |
Carla M Williams, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Dr. Samuel Joseph Sillitti, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |